Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1952 1
1956 2
1957 1
1958 7
1959 1
1961 7
1962 14
1963 15
1964 11
1965 13
1966 10
1967 17
1968 18
1969 5
1970 18
1971 27
1972 27
1973 27
1974 38
1975 42
1976 43
1977 37
1978 55
1979 65
1980 55
1981 62
1982 45
1983 41
1984 48
1985 80
1986 76
1987 124
1988 145
1989 158
1990 141
1991 154
1992 216
1993 214
1994 269
1995 290
1996 344
1997 358
1998 483
1999 574
2000 715
2001 806
2002 946
2003 1122
2004 1371
2005 1615
2006 1796
2007 2141
2008 2606
2009 2987
2010 3454
2011 3886
2012 4287
2013 4569
2014 4795
2015 4975
2016 5099
2017 5048
2018 5312
2019 5281
2020 5572
2021 5919
2022 2245
Text availability
Article attribute
Article type
Publication date

Search Results

72,085 results
Results by year
Filters applied: . Clear all
Page 1
Survival with Cemiplimab in Recurrent Cervical Cancer.
Tewari KS, Monk BJ, Vergote I, Miller A, de Melo AC, Kim HS, Kim YM, Lisyanskaya A, Samouëlian V, Lorusso D, Damian F, Chang CL, Gotovkin EA, Takahashi S, Ramone D, Pikiel J, Maćkowiak-Matejczyk B, Guerra Alía EM, Colombo N, Makarova Y, Rischin D, Lheureux S, Hasegawa K, Fujiwara K, Li J, Jamil S, Jankovic V, Chen CI, Seebach F, Weinreich DM, Yancopoulos GD, Lowy I, Mathias M, Fury MG, Oaknin A; Investigators for GOG Protocol 3016 and ENGOT Protocol En-Cx9. Tewari KS, et al. Among authors: kim ym. N Engl J Med. 2022 Feb 10;386(6):544-555. doi: 10.1056/NEJMoa2112187. N Engl J Med. 2022. PMID: 35139273 Clinical Trial.
ISPD peritonitis guideline recommendations: 2022 update on prevention and treatment.
Li PK, Chow KM, Cho Y, Fan S, Figueiredo AE, Harris T, Kanjanabuch T, Kim YL, Madero M, Malyszko J, Mehrotra R, Okpechi IG, Perl J, Piraino B, Runnegar N, Teitelbaum I, Wong JK, Yu X, Johnson DW. Li PK, et al. Among authors: kim yl. Perit Dial Int. 2022 Mar;42(2):110-153. doi: 10.1177/08968608221080586. Perit Dial Int. 2022. PMID: 35264029 Free article.
Artificial Intelligence-Powered Spatial Analysis of Tumor-Infiltrating Lymphocytes as Complementary Biomarker for Immune Checkpoint Inhibition in Non-Small-Cell Lung Cancer.
Park S, Ock CY, Kim H, Pereira S, Park S, Ma M, Choi S, Kim S, Shin S, Aum BJ, Paeng K, Yoo D, Cha H, Park S, Suh KJ, Jung HA, Kim SH, Kim YJ, Sun JM, Chung JH, Ahn JS, Ahn MJ, Lee JS, Park K, Song SY, Bang YJ, Choi YL, Mok TS, Lee SH. Park S, et al. Among authors: kim yj. J Clin Oncol. 2022 Mar 10:JCO2102010. doi: 10.1200/JCO.21.02010. Online ahead of print. J Clin Oncol. 2022. PMID: 35271299
From the Internet Editor.
Kim YJ. Kim YJ. Occup Ther Health Care. 2022 Apr;36(2):197-198. doi: 10.1080/07380577.2022.2040177. Epub 2022 Feb 17. Occup Ther Health Care. 2022. PMID: 35174739 No abstract available.
ECG of the Month.
Kim YM, Kim JH. Kim YM, et al. J Am Vet Med Assoc. 2022 Apr 27:1-3. doi: 10.2460/javma.20.08.0480. Online ahead of print. J Am Vet Med Assoc. 2022. PMID: 35482564 No abstract available.
Cosmetic Coloration: A Review.
Kim Y, Lee J. Kim Y, et al. J Cosmet Sci. 2021 Jul-Aug;72(4):442-498. J Cosmet Sci. 2021. PMID: 35262484 Review.
Update on the POEMS syndrome.
Kim YR. Kim YR. Blood Res. 2022 Apr 30;57(S1):27-31. doi: 10.5045/br.2022.2022001. Blood Res. 2022. PMID: 35483922 Free PMC article. Review.
Lessons from tough cases.
Kim YK. Kim YK. J Korean Assoc Oral Maxillofac Surg. 2022 Feb 28;48(1):1-2. doi: 10.5125/jkaoms.2022.48.1.1. J Korean Assoc Oral Maxillofac Surg. 2022. PMID: 35221301 Free PMC article. No abstract available.
72,085 results
You have reached the last available page of results. Please see the User Guide for more information.